Press Releases Stay on top of the latest news from Poseida Therapeutics. Learn about our leading-edge cell and gene therapy programs, from new discoveries to clinical trials, and get the most recent investor news. IR Sub Menu Investors & Media Corporate Profile Press Releases Events & Presentations Publications Year None20222021202020192018201720162015 Poseida Therapeutics Announces Virtual 2022 Annual Meeting of Stockholders 06/02/2022 Poseida Therapeutics Appoints Charles M. Baum, M.D., Ph.D., to Board of Directors 05/18/2022 Poseida Therapeutics Presents Encouraging Preclinical Data Highlighting P-ckit-ALLO1 at the ASGCT 2022 Annual Meeting 05/17/2022 Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2022 05/12/2022 Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting 05/02/2022 Poseida Therapeutics to Present at BofA Securities 2022 Healthcare Conference 04/28/2022 Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021 03/10/2022 Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 03/01/2022 Poseida Therapeutics Hosts Second Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations 02/23/2022 Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy 02/22/2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 96
Year None20222021202020192018201720162015 Poseida Therapeutics Announces Virtual 2022 Annual Meeting of Stockholders 06/02/2022 Poseida Therapeutics Appoints Charles M. Baum, M.D., Ph.D., to Board of Directors 05/18/2022 Poseida Therapeutics Presents Encouraging Preclinical Data Highlighting P-ckit-ALLO1 at the ASGCT 2022 Annual Meeting 05/17/2022 Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2022 05/12/2022 Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting 05/02/2022 Poseida Therapeutics to Present at BofA Securities 2022 Healthcare Conference 04/28/2022 Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021 03/10/2022 Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 03/01/2022 Poseida Therapeutics Hosts Second Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations 02/23/2022 Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy 02/22/2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 96
Poseida Therapeutics Presents Encouraging Preclinical Data Highlighting P-ckit-ALLO1 at the ASGCT 2022 Annual Meeting 05/17/2022
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting 05/02/2022
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021 03/10/2022
Poseida Therapeutics Hosts Second Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations 02/23/2022